Shanghai Shyndec Pharmaceutical Co Ltd Cash Flow Quality Index
Shanghai Shyndec Pharmaceutical Co Ltd cash flow quality index. Shanghai Shyndec Pharmaceutical Co Ltd (600420) has a Cash Flow Quality Index of 3.76x as of September 2025. Operating cash flow of CN¥486.04 Million exceeds net income of CN¥129.10 Million, indicating high earnings quality where cash backs reported profits. See 600420 financial flexibility index to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Shanghai Shyndec Pharmaceutical Co Ltd (2004–2025)
Cash flow quality index of Shanghai Shyndec Pharmaceutical Co Ltd from 2004 to 2025. Historical Cash Flow Quality Index for Shanghai Shyndec Pharmaceutical Co Ltd across 22 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore 600420 operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
Shanghai Shyndec Pharmaceutical Co Ltd Cash Flow Quality Index by Year (2004–2025)
Shanghai Shyndec Pharmaceutical Co Ltd cash flow quality index by year from 2004 to 2025. Year-by-year earnings quality comparison for Shanghai Shyndec Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see 600420 cash flow metrics.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.80x | CN¥1.70 Billion | CN¥944.38 Million | ▲ +6.2% |
| 2024 | 1.69x | CN¥2.26 Billion | CN¥1.33 Billion | ▼ -5.0% |
| 2023 | 1.78x | CN¥1.72 Billion | CN¥964.61 Million | ▼ -60.8% |
| 2022 | 4.55x | CN¥2.86 Billion | CN¥627.79 Million | ▲ +53.9% |
| 2021 | 2.96x | CN¥1.68 Billion | CN¥568.28 Million | ▲ +70.5% |
| 2020 | 1.73x | CN¥1.56 Billion | CN¥900.05 Million | ▲ +26.7% |
| 2019 | 1.37x | CN¥1.27 Billion | CN¥928.47 Million | ▼ -12.3% |
| 2018 | 1.56x | CN¥1.67 Billion | CN¥1.07 Billion | ▼ -44.8% |
| 2017 | 2.83x | CN¥2.31 Billion | CN¥818.57 Million | ▲ +188.0% |
| 2016 | 0.98x | CN¥838.58 Million | CN¥854.03 Million | ▲ +26.3% |
| 2015 | 0.78x | CN¥226.65 Million | CN¥291.55 Million | ▼ -25.6% |
| 2014 | 1.04x | CN¥258.51 Million | CN¥247.54 Million | ▼ -5.6% |
| 2013 | 1.11x | CN¥207.50 Million | CN¥187.51 Million | ▼ -13.2% |
| 2012 | 1.28x | CN¥193.41 Million | CN¥151.67 Million | ▲ +37.6% |
| 2011 | 0.93x | CN¥136.12 Million | CN¥146.92 Million | ▲ +7.2% |
| 2010 | 0.86x | CN¥115.11 Million | CN¥133.12 Million | ▼ -3.5% |
| 2009 | 0.90x | CN¥97.43 Million | CN¥108.70 Million | ▲ +12.1% |
| 2008 | 0.80x | CN¥58.04 Million | CN¥72.58 Million | ▲ +9.9% |
| 2007 | 0.73x | CN¥82.31 Million | CN¥113.11 Million | ▼ -34.5% |
| 2006 | 1.11x | CN¥73.60 Million | CN¥66.29 Million | ▲ +35.3% |
| 2005 | 0.82x | CN¥57.90 Million | CN¥70.53 Million | ▲ +134.7% |
| 2004 | 0.35x | CN¥17.02 Million | CN¥48.66 Million | — |